location： Current position: Home >> Scientific Research >> Paper Publications

Combination treatment of Ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer

Hits:

Affiliation of Author(s):药学院

Journal:Drug Discovery Therapeutics

All the Authors:liuxinyong

First Author:guoxiuli

Indexed by:Unit Twenty Basic Research

Document Code:lw-158888

Volume:8

Issue:1

Page Number:33

Translation or Not:no

Date of Publication:2014-03-01

Pre One:Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats

Next One: DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University

Click:Times MOBILE Version
The Founding Time : ..
The Last Update Time : ..

Mobile phone sweep